Crispr Therapeutics: The Recent 40% Drop In Short Interest Indicates Deteriorating Bearish SentimentSeeking Alpha • Tuesday
CRISPR Therapeutics to Present at the 2026 Jefferies Global Healthcare ConferenceGlobeNewsWire • Tuesday
CRISPR Therapeutics Presents Phase 1b Data for CTX310® Demonstrating Reductions in ANGPTL3 and Triglycerides in Patients with Severe Hypertriglyceridemia at the American Heart Association (AHA) Scientific Sessions 2026GlobeNewsWire • Monday
CRISPR Therapeutics Provides Update on Zugocabtagene Geleucel (Zugo-cel) in Refractory Rheumatologic Autoimmune DiseasesGlobeNewsWire • 11/08/26
CRISPR Therapeutics AG (CRSP) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 11/06/26
CRISPR Therapeutics to Present Clinical Data from Zugo-cel in Large B-Cell Lymphoma at the 68th American Society of Hematology (ASH) Annual Meeting and ExpositionGlobeNewsWire • 11/04/26
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/02/26
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial ResultsGlobeNewsWire • 11/02/26
CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseZacks Investment Research • 11/02/26
CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical OfficerGlobeNewsWire • 11/02/26
Here's Why CRISPR Therapeutics AG (CRSP) Fell More Than Broader MarketZacks Investment Research • 10/30/26
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should KnowZacks Investment Research • 10/23/26
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to KnowZacks Investment Research • 10/23/26
Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a BetZacks Investment Research • 10/21/26
Cathie Wood Bought More CRISPR Therapeutics Stock 2 Days in a Row. Here's What She Sees in the Biotech Stock.The Motley Fool • 10/18/26
CRISPR Therapeutics AG (CRSP) Falls More Steeply Than Broader Market: What Investors Need to KnowZacks Investment Research • 10/16/26
Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending StockZacks Investment Research • 10/12/26
CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2026GlobeNewsWire • 10/08/26
CRISPR Therapeutics AG (CRSP) Stock Slides as Market Rises: Facts to Know Before You TradeZacks Investment Research • 10/06/26